Linking Dose, Exposure, and Response
Pharmacokinetic / Pharmacodynamic (PK/PD) modeling provides a quantitative framework to understand how drugs behave in the body and how they produce their effects. We support data‑driven decisions across drug development, optimization, and regulatory strategy.
What We Do
- Pharmacokinetic (PK) modeling: absorption, distribution, metabolism, elimination
- Pharmacodynamic (PD) modeling: exposure–response relationships
- Population PK/PD and mixed‑effects models
- Dose optimization and regimen design
- Simulation for clinical trial design and decision‑making
Use Cases
- Drug development & translational research
- Clinical trial design and optimization
- Personalized and precision medicine
- Biomedical and pharmaceutical research
Our Approach
- Data integration from preclinical and clinical studies
- Mechanistic and semi‑mechanistic models
- Nonlinear mixed‑effects modeling
- Model validation, uncertainty, and sensitivity analysis
- Scenario simulations to support go/no‑go decisions
Why It Matters
- Optimize dosing strategies and improve efficacy
- Reduce toxicity and inter‑patient variability
- Support evidence‑based clinical development
- Strengthen regulatory submissions with quantitative insights
LET’S COLLABORATE
Ready to turn quantitative models into better therapeutic decisions?
Ateba & Partners Consulting helps organizations transform biomedical data into robust, actionable insights.
Contact us to discuss your project confidentially.